Breakthrough Therapy for Iron Deficiency Anemia
Investors 1
Funding Rounds 2
| Date | Series | Amount | Investors |
| 15.08.2016 | - | $3.5M | - |
| 02.03.2016 | Series B | $11M | - |
Mentions in press and media 5
| Date | Title | Description |
| 31.08.2016 | Ten Life Science Companies to Watch in San Antonio | By LAURA LOREK
Reporter with Silicon Hills News |
| 15.08.2016 | InCube Labs Company Fe3 Medical Receives $3.5M from the State of Texas | Fe3 Medical, a San Antonio, TX-based InCube Labs company, raised $3.5M as part of an extension to its Series B round.
The investment from the State of Texas brought total Series B funding to $14.5M, which will be used for product developmen... |
| 03.03.2016 | Fe3 brings in $11M Series B for iron patch designed for anemic patients | The primary market for those who could benefit from this patch are people losing blood from menstruation or the gastrointestinal tract, those with chronic illness such as kidney failure, cancer, Crohn’s and GI disorders, as well as increase... |
| 02.03.2016 | Fe3 Medical Closes $11M Series B Financing | Fe3 Medical, a San Antonio, Texas-based developer of a transdermal patch that delivers iron across the skin for patients suffering from iron-deficiency anemia, closed an $11m Series B financing.
Backers included Jianmin Pharmaceuticals, HG ... |
| - | Fe3 brings in $11M Series B for iron patch designed for anemic patients | Fe3 announced today that it has closed a $11 million Series B round do further develop its transdermal patch that delivers iron for anemic patients.
The San Antonio, Texas-based company comes out of the InCube Labs incubator. The next phase... |
Reviews 0
